Effects of Cyclooxygenase-2 Inhibitor on Gastric Acid Secretion in Helicobacter pylori-infected C57BL/6 Mice

References

• Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992;102:720–7.
   PubMed Web of Science ®Google Scholar
• Moss S, Calam J. Helicobacter pylori and peptic ulcers: the present position. Gut 1992;33:289–92.
   PubMed Web of Science ®Google Scholar
• Peura DA. Ulcerogenesis: integrating the roles of Helicobacter pylori and acid secretion in duodenal ulcer. Am J Gastroenterol 1997;92:8S–13S.
   Google Scholar
• Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J.Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989;1: 1167–8.
   Google Scholar
• Konturek PC, Konturek SJ. Role of Helicobacter pylori infection in gastro-duodenal secretion and in pathogenesis of peptic ulcer and gastritis. J Physiol Pharmacol 1994;45:333–50.
   PubMedGoogle Scholar
• El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15–24.
   PubMed Web of Science ®Google Scholar
• Furuta T, Baba S, Takashima M, Futami H, Arai H, Kajimura M, et al. Effect of Helicobacter pylori infection on gastric juice pH. Scand J Gastroenterol 1998;33:357–63.
   PubMed Web of Science ®Google Scholar
• Williams CS, DuBois RN. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 1996;270:G393–400.
   PubMed Web of Science ®Google Scholar
• Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979;77:761–7
   PubMed Web of Science ®Google Scholar
• Whittle BJR, Vane JR. Prostanoids as regulators of gastrointestinal function. In: Johnson LR, editor. Physiology of the gastrointestinal tract. 2nd ed. New York: Raven; 1987. p. 143–80.
   Google Scholar
• Oderda G, D’Alessandro M, Mariani P, Lionetti P, Bonamico M, Dell’Olio D, et al. Prostaglandin E2 in gastric mucosa of children with Helicobacter pylori gastritis: relation to thickness of mucus gel layer. J Clin Pathol 1993;46:836–9.
   PubMed Web of Science ®Google Scholar
• Romano M, Ricci V, Memoli A, Tuccillo C, Di Popolo A, Sommi P, et al. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 1998;273: 28560–3.
   PubMed Web of Science ®Google Scholar
• Lee A, O’Rourke J, De Ungria MC, Robertson B, Daskalopou- los G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112: 1386–97.
   Google Scholar
• Fox JG, Li X, Cahill RJ, Andrutis K, Rustgi AK, Odze R, et al. Hypertrophic gastropathy in Helicobacter /elis-infected wildtype C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology 1996;110:155–66.
   PubMed Web of Science ®Google Scholar
• McCarthy CJ, Crofford LJ, Greenson J, Scheiman JM. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. Am J Gastroenterol 1999;94:1218–23.
   PubMed Web of Science ®Google Scholar
• Sawaoka H, Kawano S, Tsuji S, Tsuji M, Sun W, Gunawan ES, et al. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostag Leukotr Ess 1998;59:313–6.
   PubMed Web of Science ®Google Scholar
• Glaser K, Sung ML, O’Neill K, Belfast M, Hartman D, Carlson R, et al. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol 1995;281: 107–11.
   Google Scholar
• Dvornik DM. Tissue selective inhibition of prostaglandin biosynthesis by etodolac. J Rheumatol Suppl 1997;47:40–7.
   PubMedGoogle Scholar
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996;20:1161–81.
   PubMed Web of Science ®Google Scholar
• Courillon-Mallet A, Launay JM, Roucayrol AM, Callebert J, Emond JP, Tabuteau F, et al. Helicobacter pylori infection: physiopathologic implication of N alpha-methyl histamine. Gastroenterology 1995;108: 959–66.
   Google Scholar
• Cave DR, Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 1989;2:187–9.
   PubMed Web of Science ®Google Scholar
• Beil W, Birkholz C, Wagner S, Sewing KF. Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H+/K(+)-ATPase. Gut 1994;35:1176–80.
   PubMed Web of Science ®Google Scholar
• Kondo S, Shinomura Y, Kanayama S, Kawabata S, Miyazaki Y, Imamura I, et al. Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am J Physiol 1994;267:G966–71.
   PubMedGoogle Scholar
• Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473–7.
   PubMed Web of Science ®Google Scholar
• Jackson BA, Goldstein RH, Roy R, Cozzani M, Taylor L, Polgar P. Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun 1993;197:1465–74.
   PubMed Web of Science ®Google Scholar
• Kniss DA, Zimmerman PD, Fertel RH, Iams JD. Proinflammatory cytokines interact synergistically with epidermal growth factor to stimulate PGE2 production in amnion-derived cells. Prostaglandins 1992;44:237–44.
   PubMed Web of Science ®Google Scholar
• Sautereau D, Chicau-Chovet M, Tsocas A, Roze C. Central and peripheral effects of prostaglandin E2 and enprostil on gastric acid secretion in the rat. Eur J Pharmacol 1991;195:217–24.
   PubMed Web of Science ®Google Scholar
• Feldman M. Gastric bicarbonate secretion in humans. Effect of pentagastrin, bethanechol, and 11,16,16-trimethyl prostaglandin E2. J Clin Invest 1983;72: 295–303.
   Google Scholar
• Robert A, Olafsson AS, Lancaster C, Zhang WR. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci 1991;48: 123–34.
   PubMed Web of Science ®Google Scholar
• Saperas ES, Yang H, Rivier C, Tache Y. Central action of recombinant interleukin-1 to inhibit acid secretion in rats. Gastroenterology 1990;99:1599–606.
   PubMed Web of Science ®Google Scholar
• Seidler U, Beinborn M, Sewing KF. Inhibition of acid formation in rabbit parietal cells by prostaglandins is mediated by the prostaglandin E2 receptor. Gastroenterology 1989;96: 314–20.
   Google Scholar
• Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, et al. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 2000;157:729–35.
   PubMed Web of Science ®Google Scholar
• Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 1999;116:1319–29.
   PubMed Web of Science ®Google Scholar
• Tatsuguchi A, Sakamoto C, Wada K, Akamatsu T, Tsukui T, Miyake K, et al. Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut 2000;46:782–9.
   PubMed Web of Science ®Google Scholar
• Ruiz B, Correa P, Fontham ET, Ramakrishnan T. Antral atrophy, Helicobacter pylori colonization, and gastric pH. Am J Clin Pathol 1996;105:96–101.
   PubMed Web of Science ®Google Scholar
• Karttune T, Niemela S, Lehtola J. Helicobacter pylori in dyspeptic patients: quantitative association with severity of gastritis, intragastric pH, and serum gastrin concentration. Scand J Gastoenterol Suppl 1991;186: 124–34.
   Google Scholar
• Correa P, Haenszel W, Cuello C, Zavala D, Fontham E, Zarama G, et al. Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 1990;50:4731–6.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998;115:642–8.
   PubMed Web of Science ®Google Scholar
• Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998;58:4255–9.
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000;118: 22–30.
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404: 398–402.
   Google Scholar
• Uefuji K, Ichikura T, Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res 2000;6: 135–8.
   Google Scholar